Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

被引：0
|
作者：
H-M Lin
L Castillo
K L Mahon
K Chiam
B Y Lee
Q Nguyen
M J Boyer
M R Stockler
N Pavlakis
G Marx
G Mallesara
H Gurney
S J Clark
A Swarbrick
R J Daly
L G Horvath
机构：
[1] The Kinghorn Cancer Centre/Garvan Institute of Medical Research,Cancer Research Division
[2] Sydney Medical School,Department of Medical Oncology
[3] University of Sydney,undefined
[4] Pharmacogenomic Research for Individualised Medicine (PRIMe) consortium,undefined
[5] Chris O’Brien Lifehouse,undefined
[6] Royal Prince Alfred Hospital,undefined
[7] Medical Oncology,undefined
[8] Concord Repatriation General Hospital,undefined
[9] Concord,undefined
[10] Medical Oncology,undefined
[11] Royal North Shore Hospital,undefined
[12] Northern Haematology and Oncology Group,undefined
[13] Sydney Adventist Hospital,undefined
[14] Calvary Mater Newcastle Hospital,undefined
[15] Westmead Hospital,undefined
[16] St Vincent’s Clinical School,undefined
[17] Faculty of Medicine,undefined
[18] UNSW Australia,undefined
[19] Signalling Network Laboratory,undefined
[20] School of Biomedical Sciences,undefined
[21] Monash University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
circulating microRNAs; chemotherapy; metastatic prostate cancer; biomarkers; docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2462 / 2471
页数：9
相关论文
共 50 条
  • [11] Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer
    Okegawa, Takatsugu
    Itaya, Naoshi
    Hara, Hidehiko
    Tambo, Mitsuhiro
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (11) : 6705 - 6710
  • [12] Chemotherapy for castration-resistant prostate cancer
    Berthold, D.
    ONKOLOGIE, 2011, 34 : 12 - 12
  • [13] Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer
    Christoph W. M. Reuter
    Michael A. Morgan
    Philipp Ivanyi
    Martin Fenner
    Arnold Ganser
    Viktor Grünwald
    World Journal of Urology, 2010, 28 : 391 - 398
  • [14] Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer
    Reuter, Christoph W. M.
    Morgan, Michael A.
    Ivanyi, Philipp
    Fenner, Martin
    Ganser, Arnold
    Gruenwald, Viktor
    WORLD JOURNAL OF UROLOGY, 2010, 28 (03) : 391 - 398
  • [15] Oncological outcome of docetaxel-based chemotherapy for Japanese men with metastatic castration-resistant prostate cancer
    Miyake, Hideaki
    Sakai, Iori
    Terakawa, Tomoaki
    Harada, Ken-ichi
    Fujisawa, Masato
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (06) : 733 - 738
  • [16] INTERMITTENT (RECHALLENGE) CHEMOTHERAPY WITH DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Bracarda, Sergio
    Rossi, Marta
    Hamzaj, Alketa
    De Angelis, Verena
    De Simone, Valeria
    Caserta, Claudia
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2009, 20
  • [17] PREDICTION OF LEUKOPENIA AFTER DOCETAXEL CHEMOTHERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
    Nakashima, Jun
    Takizawa, Issei
    Ko, Kazuyoshi
    Nakagami, Yoshihiro
    Ohori, Makoto
    Ohno, Yoshio
    Yoshioka, Kunihiko
    Tachibana, Masaaki
    JOURNAL OF UROLOGY, 2012, 187 (04): : E311 - E311
  • [18] The Oncological Outcomes and Risk Stratification in Docetaxel Chemotherapy for Castration-resistant Prostate Cancer
    Shiota, Masaki
    Yokomizo, Akira
    Adachi, Takumi
    Koga, Hirofumi
    Yamaguchi, Akito
    Imada, Kenjiro
    Takeuchi, Ario
    Kiyoshima, Keijiro
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Naito, Seiji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (09) : 860 - 867
  • [19] Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    Szarvas, Tibor
    Sevcenco, Sabina
    Modos, Orsolya
    Keresztes, David
    Nyirady, Peter
    Kubnik, Andras
    Romics, Miklos
    Kovalszky, Ilona
    Reis, Henning
    Hadaschik, Boris
    Shariat, Shahrokh F.
    Kramer, Gero
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 312.e9 - 312.e15
  • [20] Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
    Salvi, Samanta
    Casadio, Valentina
    Conteduca, Vincenza
    Lolli, Cristian
    Gurioli, Giorgia
    Martignano, Filippo
    Schepisi, Giuseppe
    Testoni, Sara
    Scarpi, Emanuela
    Amadori, Dino
    Calistri, Daniele
    Attard, Gerhardt
    De Giorgi, Ugo
    ONCOTARGET, 2016, 7 (25) : 37839 - 37845
12345